Ephedra Imports Legal While Nutraceutical Appeal Underway – Emord
This article was originally published in The Tan Sheet
Executive Summary
FDA's refusal to allow Hong Kong-based broker EMAX to import ephedra-containing dietary supplements into the U.S. violates an April 2005 court ruling which invalidated the agency's ban on the botanical, according to a lawsuit filed April 21 by the firm Emord & Associates